Adaptimmune Therapeutics shares owned by ACT Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by ACT Capital Management
from 13F filings
Historical chart of ACT Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by ACT Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-09-30 | $97k | 90k | 1.08 |
| 2022-06-30 | $153k | 90k | 1.70 |
| 2022-03-31 | $185k | 90k | 2.06 |
| 2021-12-31 | $338k | 90k | 3.76 |
| 2021-09-30 | $465k | 90k | 5.17 |